The secret of Nanjing Tongren Temple: Sambo group or "real master"
Source: Internet
Author: User
KeywordsNanjing
Nanjing Tong Tang People behind the scenes: Sambo group or "real Master" reporter from the Nanjing Trade and Industry Bureau obtained the industry and commerce information, Nanjing Tongren Tong Company registered capital of 50 million yuan. Among them, Nanjing with Chun Investment Management Co., Ltd. (hereinafter referred to as the Nanjing June) capital contribution of 30 million yuan, accounted for 60%; Nanjing Pharmaceutical International Health Industry Co., Ltd. said (South Medicine International) to invest 20 million yuan, accounting for 40%. Financial profit Po, the current savings rate increased by 1000% and Nanjing with June by South Medicine International 100% Holding, then, who is the actual control of the South Medicine International, who is the Nanjing Tong Tang Real "master". South Medicine International Life and trade data show that the South Medicine international was established in December 7, 2009, registered in Nanjing City, Yuhuatai District Small line 1th, the legal representative of Xu Xi, registered capital of 225 million yuan, for the Jiangsu Red Stone Technology Industrial Co., Ltd. (hereinafter referred to as Jiangsu Redstone) exclusive shareholding. During the investigation in Nanjing, the reporter learned that the history of the South Medicine International is "wonderful", after several shares of the movement has become a natural person's assets, and its earliest Nanjing pharmaceutical wholly-owned companies. December 7, 2009, the South Medicine international name is still called "Nanjing Artis Kang Real Estate Development Co., Ltd." (hereinafter called Artis Kang Real Estate), registered capital of 10 million yuan, paid-in capital of 3 million yuan, the legal representative is Shizhong, business scope is "real estate development, management." The amount of capital contribution of Nanjing Medicine is 9 million yuan, the shareholding is 90%, Shanghai Tian Ze Source Investment Co., Ltd. (Nanjing Pharmaceutical subsidiary) Capital contribution is 1 million yuan, the shareholding ratio is 10%. February 3, 2010, the Artis will change the name of the company to Nanjing Kang Real Estate Development Co., Ltd. (hereinafter called Nanjing Kang). August 16, 2011, Shanghai Tian Ze source will be its holdings of Nanjing Kang Real estate 10% of the stake to 1 million yuan transferred to Nanjing Medicine, and on September 5, 2011 for industrial and commercial change. November 28 that year, Nanjing medicine to Qi Kang Real estate to increase the capital 80 million yuan. After the completion of the increase in capital, Qi Kang Real estate to increase the registration of 90 million yuan, the company name at the same time changed to "Nanjing Pharmaceutical International Health Industry Co., Ltd.". On the same day, NAM International decided to waive the directorship of Ten Covu, Shizhong, Li Zhen, Chen Yu and Liao Hong, to appoint Ding, He Jinxian and Wang Huiqing as new directors, and to elect Ding as chairman of the company and as the legal representative and general manager of the company. Data show that Ding has been Beijing Step Venture Capital Co., Ltd. General manager, the United States Kang Tan Biological Group, vice president, since January 2008, Nanjing Pharmaceutical Director, executive vice president. In the 10 days after the increase in funding, December 7, 2011, Nanjing Pharmaceutical Board of directors agreed to Jiangsu Red Stone to the south of the international capital increase of 135 million yuan, the company waived the corresponding priority to increase capital rights. For why the listed companies give up the same proportion of capital increase, Nanjing Medicine did not make a detailed explanation. After the completion of this replenishment, the registered capital of South Medicine international increased to 225 million yuan, of whichNanjing Pharmaceutical Investment amount of 90 million yuan, accounting for its registered capital of 40%, Jiangsu Red Stone contribution amount of 135 million yuan, accounting for its registered capital of 60%. Nan Pharmaceutical International therefore changed to Nanjing Pharmaceutical Joint-stock subsidiary, no longer included in the consolidated statement scope. According to industry and commerce information, at that time, the original board members of South Medicine International did not change, and the election of Shan cattle, Yushanmin, M.D. and Xu Xi as the company's new director. Three days later, December 10, Nanjing Medicine to the south of the international Transfer of Medicine held Xuzhou medicine 81.07% shares, Nanjing Life can 35% equity, Nanjing Tongren Temple 100% Equity, Tongren Temple Huangshan 58.93% stake, Tongren temple Hongze 87% shares, The Yangtze Chuan Medicine 93.6% Equity, the total Price is 28,793.610,000 yuan. Among them, Tongren temple Huangshan, Tongren temple Hongze stock price is only 1 yuan respectively. February 2, 2012, the second session of the Board of Directors of South Medicine International in 2012 removed Ding chairman from office, elected Xu Xi as chairman and served as legal representative. Ding elected Vice chairman and continued as general manager. June 25, South Medicine International 2012 second shareholders will change the scope of business, remove the "real estate development, management", only to retain "animal and plant culture (Limited branch operation)". June 30, Nanjing Pharmaceutical International transfer Nanjing Heng Sheng Pharmaceutical Co., Ltd. 60% Equity, the transfer price of 22.1618 million yuan. After the transfer of the above equity, Nanjing Medicine's next move but let investors "confused". September 27, the South Medicine International 2012 Fourth Times shareholders will agree that Nanjing Medical voluntary withdrawal, and its 90 million yuan money, accounting for 40% of the registered capital, transfer to Jiangsu Red Stone, the transfer price of 83.384 million yuan. At the same time, the South Medicine International exempts Ding, He Jinxian and Xu Yuanyuan Company Board of Directors, the board members are the Yuan man cattle, Xu Xi and M.D.. On the same day, the first meeting of the third Board of the South Medicine international was removed from the post of Ding vice chairman and continued to be appointed as general manager. At the same time, elect Xu Xi as Chairman and act as legal representative. October 9, Nanjing Medical Bulletin said that the company intends to transfer to Jiangsu South Medicine International 40% Equity, the transfer price of 83.384 million yuan. After the transfer, Jiangsu Red Stone holds the South Medicine international 100% Equity. Equity investment alone, Nanjing medicine to the south of the international investment of 90 million yuan, and the company gave up all the South Medicine international equity only 83.384 million yuan. October 12, the South Medicine international changed the scope of business again, except "Animal and Plant culture (Limited branch operation)", but also increased "prepackaged food and bulk food wholesale and retail, health food wholesale, retail." Who controls the red stone of Jiangsu today, the South Medicine International has become the 100% holding subsidiary of Jiangsu Red Stone, then who controls the red stone in Jiangsu? Nanjing Medical Bulletin shows that the Jiangsu Red Stone was established in April 12, 2005, registered in Nanjing City Baixia District Alfalfa Garden Street West No. 6thRoom 101-105, the legal representative of the yuan human cattle, registered capital of 40 million yuan. The shareholding structure of the company is RMB 28 million, which accounts for 70% of its registered capital, and the Nanjing Huixin Electronic Technology Co., Ltd. (hereinafter referred to as Nanjing Hui Baofeng) has invested 12 million yuan, accounting for 30% of its registered capital. According to the reporter obtained the Jiangsu Red Stone Industry and commerce data show, Jiangsu Red Stone was originally called Jiangsu century Taurus Branch industry and Trade Industrial Co., Ltd. (hereinafter referred to as Taurus), its shareholding structure for Jiangsu Rui Fu Intelligent Technology Co., Ltd. (hereinafter called JIANGSURIFA) capital contribution of 8 million yuan, accounting for more than 80% , Jiangsu National Letter Industry and Trade Co., Ltd. Investment 2 million yuan (hereinafter referred to as Jiangsu National Letter), accounting for 20%. April 8, 2005, the first shareholder of the century Taurus was attended by Liyun and Zhang Hua, who elected the Executive director as Yang Wenxia, and the supervisor was Ye Yousen. Nanjing, a person told reporters, Jiangsu Rifford is the Nanjing Sambo Technology [0%] Group Co., Ltd. (hereinafter called the Sambo Group) 2003 Investment Enterprises, specializing in the UHF RFID technology and product development, "Now the company is still the gem of the science and Technology park inside." Zhang Hua is the representative of the Sambo group, Liyun is a representative of Jiangsu National Letter. "It is noteworthy that Nanjing Medicine in August this year just transferred Nanjing Tongren Temple Huangshan Refining Pharmaceutical Co., Ltd. (hereinafter referred to as Ren Tong Mountain), its predecessor Huangshan Bailing Pharmaceutical Co., Ltd. is by Jiangsu Rifford and Yang Wenxia on January 14, 2005 jointly financed the establishment of a registered capital of 1 million yuan, of which the Jiangsu Rifford Capital 950,000 Yuan, Accounting for 95% of registered capital and Yang Wenxia of 50,000 yuan, accounting for 5% of registered capital. August 2005, the Century Taurus to the Tongren temple Huangshan increased capital of 9 million yuan, accounting for 90% of the registered capital, become its first major shareholder. After that, the century Taurus equity change, January 8, 2006, Jiangsu Fu Rui will hold 80% stake to the Wang Yanqing. At the same time, Jiangsu State Letter to the century Taurus increased capital of 30 million yuan. After the increase, the century Taurus registered capital amounted to 40 million yuan, Jiangsu state letter accounted for 80%, Wang Yanqing accounted for 20%. March 2007, Jiangsu Rifford and Yang Wenxia will hold the Tongren Temple Huangshan all equity (ie 10%) transfer to Wu Feng. The same month, Jiangsu National letter to 32 million yuan will be held in the century Taurus 80% shares to the natural person Go Jun, and removed Yang Wenxia executive director position. Sambo Group in Hong Kong listed Enterprises-Sambo technology (08287. HK) shows that one of its non-executive directors is also called Go Jun. The reporter also learned that the Gem group, the actual control of the Phenyltoloxamine from Southeast University, and its alumni have a Nanjing in the Real Estate Co., Ltd. (hereinafter referred to as the general manager of the company) is also called Go Jun. November 7, 2008, Phenyltoloxamine and Go Jun joined the Southeast University of Kowloon Lake Alumni Association. Jiangsu Red Stone 2012 Annual inspection report shows that it holds 64% stake in China-owned property. April 2009, May, the century Taurus and Wu Feng will hold the Tongren temple Huangshan 90%, 10% Equity transfer to Sambo group. The same year in September, the Sambo group will be the Tang Shan to Nanjing Pharmaceutical subsidiary of four subsidiaries. April 12, 2010, Wang Yanqing will hold 20% of the century Taurus to Shan cattle, and Go Jun will hold the century Taurus 50% stake to Shan cattle. Since then, the century Taurus equity into Yuan cattle stock 70%, Go Jun shareholding 30%, the company name into "Jiangsu Redstone Technology Industrial Co., Ltd.". Public information shows that the yuan cattle have also served as the general manager of the housing estates. The reporter also received a copy of the Jiangsu Red Stone and the triple Gem technology signed the April 28, 2010 lease contract, the Triple Gem technology will be located in Nanjing Pukou Business Villa leased to Jiangsu Red Stone. August 1, 2011, Jiangsu Red Stone will be relocated to the office site to Nanjing Alfalfa Garden West 6th. November 29, Go Jun will hold a 30% stake in Jiangsu Red Stone to Nanjing Huiyuan Electronic Technology Co., Ltd. (Nanjing Hui Baofeng), and Nanjing Hui Fung's legal representative Xu Yuanyuan was the International director of South Medicine. The same year December 7, Jiangsu Red Stone to the south of the international capital increase of 135 million yuan, became the South Medicine international holding shareholder, and after this was let Nanjing Tong Ren Tang assets. Today, Nanjing Tongren Temple chairman for the Sun Whidong, it is not only the Sambo group shareholders, but also was the triple gem of science and technology supervisors. On the surface, the Sambo group control of Jiangsu Fu Rui is only the founder of the Red Stone in Jiangsu, but the reporter learned that the Sambo group has still been linked with the Jiangsu Red Stone. Through a series of stock right maneuver, Nanjing Tang Ren Tang is behind the scenes of the Gem group figure, and Phenyltoloxamine or the current Nanjing Tongren Temple Real Controller. (21. Ji. Shi., Dao Han Xun)
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.